Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2003-5-7
pubmed:abstractText
The specificity of recognition of pMHC complexes by T lymphocytes is determined by the V regions of the TCR alpha- and beta-chains. Recent experimental evidence has suggested that Ag-specific TCR repertoires may exhibit a more V alpha- than V beta-restricted usage. Whether V alpha usage is narrowed during immune responses to Ag or if, on the contrary, restricted V alpha usage is already defined at the early stages of TCR repertoire selection, however, has remained unexplored. Here, we analyzed V and CDR3 TCR regions of single circulating naive T cells specifically detected ex vivo and isolated with HLA-A2/melan-A peptide multimers. Similarly to what was previously observed for melan-A-specific Ag-experienced T cells, we found a relatively wide V beta usage, but a preferential V alpha 2.1 usage. Restricted V alpha 2.1 usage was also found among single CD8(+) A2/melan-A multimer(+) thymocytes, indicating that V alpha-restricted selection takes place in the thymus. V alpha 2.1 usage, however, was independent from functional avidity of Ag recognition. Thus, interaction of the pMHC complex with selected V alpha-chains contributes to set the broad Ag specificity, as underlined by preferential binding of A2/melan-A multimers to V alpha 2.1-bearing TCRs, whereas functional outcomes result from the sum of these with other interactions between pMHC complex and TCR.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
170
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5103-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12734356-Amino Acid Sequence, pubmed-meshheading:12734356-Antigens, Neoplasm, pubmed-meshheading:12734356-Autoantigens, pubmed-meshheading:12734356-Cell Differentiation, pubmed-meshheading:12734356-Clone Cells, pubmed-meshheading:12734356-Cytotoxicity, Immunologic, pubmed-meshheading:12734356-Epitopes, T-Lymphocyte, pubmed-meshheading:12734356-Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor, pubmed-meshheading:12734356-Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, pubmed-meshheading:12734356-HLA-A2 Antigen, pubmed-meshheading:12734356-Hematopoietic Stem Cells, pubmed-meshheading:12734356-Humans, pubmed-meshheading:12734356-MART-1 Antigen, pubmed-meshheading:12734356-Melanoma, pubmed-meshheading:12734356-Molecular Sequence Data, pubmed-meshheading:12734356-Neoplasm Proteins, pubmed-meshheading:12734356-RNA, Messenger, pubmed-meshheading:12734356-Receptors, Antigen, T-Cell, alpha-beta, pubmed-meshheading:12734356-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:12734356-T-Lymphocytes, Cytotoxic, pubmed-meshheading:12734356-Tumor Cells, Cultured
pubmed:year
2003
pubmed:articleTitle
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
pubmed:affiliation
Division of Oncology, Laboratory of Tumor Immunology, University Hospital, Geneva, Switzerland. pierre-yves.dietrich@hcuge.ch
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't